Security Snapshot

SANFILIPPO JOHN B & SON INC - Common Stock (JBSS) Institutional Ownership

CUSIP: 800422107

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

213

Shares (Excl. Options)

8,361,034

Price

$79.33

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-7,419
Value change
+$1,746,757
Number of holders
213
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
9,020,923
SEC-reported price per share
$76.41
Insider filing price
$76.41
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • JBSS - SANFILIPPO JOHN B & SON INC - Common Stock is tracked under CUSIP 800422107.
  • 213 institutions reported positions in Q1 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 207 to 213 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $588,091,395 to $663,230,229.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 213 institutions filings for Q1 2026.

Open SEC evidence

Security key

800422107

Latest holder period

Q1 2026

13F holders

213

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
JBSS
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14% -7.3% $81,153,362 -$5,263,845 1,283,260 -6.1% BlackRock, Inc. 30 Jun 2025
THRIVENT FINANCIAL FOR LUTHERANS 9.1% -15% $57,955,822 -$10,149,950 820,904 -15% THRIVENT FINANCIAL FOR LUTHERANS 31 Dec 2025

As of 31 Mar 2026, 213 institutional investors reported holding 8,361,034 shares of SANFILIPPO JOHN B & SON INC - Common Stock (JBSS). This represents 93% of the company’s total 9,020,923 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
70%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 16% 1,415,610 +1.1% 0% $112,300,341
Thrivent Financial for Lutherans 9.1% 820,547 -0.04% 0.12% $65,094,000
VANGUARD CAPITAL MANAGEMENT LLC 4.2% 380,540 0% 0% $30,188,238
STATE STREET CORP 3.9% 347,368 -1.6% 0% $27,556,703
VANGUARD PORTFOLIO MANAGEMENT LLC 3.5% 317,634 0% 0% $25,197,905
DIMENSIONAL FUND ADVISORS LP 3.5% 312,802 +4% 0.01% $24,814,681
DEUTSCHE BANK AG\ 2.9% 257,715 +0.46% 0.01% $20,444,531
TWO SIGMA INVESTMENTS, LP 2.7% 241,148 +129% 0.02% $19,130,271
GEODE CAPITAL MANAGEMENT, LLC 2.3% 209,067 +3.1% 0% $16,589,361
GAMCO INVESTORS, INC. ET AL 2.1% 192,025 -6% 0.15% $15,233,343
RENAISSANCE TECHNOLOGIES LLC 2.1% 185,345 -8.6% 0.02% $14,703,419
ROYCE & ASSOCIATES LP 2% 183,161 -26% 0.14% $14,530,162
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.9% 174,003 -3.9% 0% $13,803,658
AMERIPRISE FINANCIAL INC 1.6% 147,129 -3.3% 0% $11,671,769
AMERICAN CENTURY COMPANIES INC 1.6% 145,065 +135% 0.01% $11,508,006
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 1.5% 137,747 -8.7% 0.03% $10,927,470
MORGAN STANLEY 1.4% 126,052 -0.42% 0% $9,999,812
Hunter Perkins Capital Management, LLC 1.4% 122,859 -9.8% 2.3% $9,746,000
JANUS HENDERSON GROUP PLC 1.1% 102,543 -7.9% 0% $8,135,363
Bank of New York Mellon Corp 1.1% 101,226 +0.28% 0% $8,030,297
GOLDMAN SACHS GROUP INC 1.1% 100,045 -0.28% 0% $7,936,582
VICTORY CAPITAL MANAGEMENT INC 1.1% 98,394 -16% 0.01% $7,805,624
NORTHERN TRUST CORP 0.95% 85,909 +4.3% 0% $6,815,161
DEAN INVESTMENT ASSOCIATES, LLC 0.86% 77,155 +11% 0.86% $6,120,706
Invenomic Capital Management LP 0.82% 73,886 -4.6% 0.27% $5,861,376

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 8,361,034 $663,230,229 +$1,746,757 $79.33 213
2025 Q4 8,329,583 $588,091,395 +$627,271 $70.60 207
2025 Q3 8,360,539 $537,406,045 -$1,557,453 $64.28 202
2025 Q2 8,436,399 $533,600,463 +$7,129,671 $63.24 186
2025 Q1 8,285,155 $586,745,617 -$3,543,126 $70.86 190
2024 Q4 8,315,401 $724,446,928 -$2,648,718 $87.11 197
2024 Q3 8,236,818 $776,431,411 -$17,280,504 $94.31 200
2024 Q2 8,369,837 $812,964,690 -$2,871,234 $97.17 188
2024 Q1 8,373,205 $885,514,788 +$18,136,623 $105.92 181
2023 Q4 8,197,055 $844,285,921 +$13,802,200 $103.04 176
2023 Q3 8,041,126 $794,521,961 -$6,030,533 $98.80 182
2023 Q2 8,059,286 $945,088,149 -$3,402,178 $117.27 185
2023 Q1 8,172,972 $792,684,249 +$14,128,163 $96.92 195
2022 Q4 8,053,604 $655,026,220 +$284,810 $81.32 180
2022 Q3 8,032,984 $608,452,847 -$7,332,947 $75.73 168
2022 Q2 8,119,463 $588,841,574 +$15,066,147 $72.49 161
2022 Q1 7,948,802 $663,324,232 +$3,580,278 $83.44 159
2021 Q4 7,892,983 $710,847,630 -$12,039,934 $90.16 166
2021 Q3 7,943,025 $648,972,365 -$17,180,817 $81.72 159
2021 Q2 8,144,415 $721,344,350 -$4,305,674 $88.57 157
2021 Q1 8,212,225 $741,722,142 +$3,029,404 $90.37 158
2020 Q4 8,181,855 $645,080,868 -$4,675,663 $78.86 161
2020 Q3 8,324,675 $626,913,640 -$8,852,039 $75.38 170
2020 Q2 8,414,538 $717,417,003 -$1,313,567 $85.33 180
2020 Q1 8,414,155 $752,103,714 +$39,856,478 $89.40 178
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .